Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
NuVasive to Participate as Double Diamond Sponsor at Scoliosis Research Society Annual Meeting

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive: Q2 Earnings Snapshot

NuVasive: Q2 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces Second Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of Second Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive: Q1 Earnings Snapshot

NuVasive: Q1 Earnings Snapshot

NUVA : 39.75 (-2.24%)
NuVasive Announces First Quarter 2023 Financial Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Announces Conference Call and Webcast of First Quarter 2023 Results

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
NuVasive Shareholders Approve Merger Agreement with Globus Medical

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
GMED : 72.05 (+3.40%)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates INFI, ANGN, NUVA, SUMO

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

INFI : 0.0080 (-50.00%)
ANGN : 10.0000 (+2.04%)
NUVA : 39.75 (-2.24%)
SUMO : 12.04 (-0.08%)
Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending NuVasive Shareholders Vote "FOR" the Proposed Merger with Globus Medical

/PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive,...

NUVA : 39.75 (-2.24%)
GMED : 72.05 (+3.40%)

Barchart Exclusives

MSFT vs. ORCL: Which AI Software Stock is a Better Buy?
Microsoft and Oracle have been leaders in developing market-leading AI software. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar